These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10619519)

  • 61. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.
    Gajra A; Newman N; Gamble GP; Kohman LJ; Graziano SL
    J Clin Oncol; 2003 Mar; 21(6):1029-34. PubMed ID: 12637467
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Induction chemotherapy for T4 centrally located non-small cell lung cancer.
    Rendina EA; Venuta F; De Giacomo T; Ciccone AM; Ruvolo G; Coloni GF; Ricci C
    J Thorac Cardiovasc Surg; 1999 Feb; 117(2):225-33. PubMed ID: 9918961
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Resection of non-small cell lung cancer: how much and by what route.
    Ginsberg RJ
    Chest; 1997 Oct; 112(4 Suppl):203S-205S. PubMed ID: 9337289
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer.
    Higgins KA; Chino JP; Ready N; Onaitis MW; Berry MF; D'Amico TA; Kelsey CR
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1175-9. PubMed ID: 22014344
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer.
    Movsas B
    Oncology (Williston Park); 2002 Jan; 16(1):90-5, 100; discussion 100-2, 105-6. PubMed ID: 11831614
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.
    Fischer S; Darling G; Pierre AF; Sun A; Leighl N; Waddell TK; Keshavjee S; de Perrot M
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1129-34. PubMed ID: 18407511
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Indications for surgery in non-small cell lung cancer with lymph node invasion].
    Bonnette P
    Rev Mal Respir; 2011 Oct; 28(8):960-6. PubMed ID: 22099401
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Surgical management of early-stage non-small cell lung carcinoma and the present and future roles of adjuvant therapy: a review for the radiation oncologist.
    Medford-Davis L; Decamp M; Recht A; Flickinger J; Belani CP; Varlotto J
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1048-57. PubMed ID: 22632771
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?].
    Pagès PB; Pforr A; Delpy JP; Abou Hanna H; Bernard A
    Rev Mal Respir; 2015 May; 32(5):485-92. PubMed ID: 25498767
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pathological complete response after neoadjuvant/induction treatment: where is its place in the lung cancer staging system?†.
    Melek H; Çetinkaya G; Özer E; Yentürk E; Sevinç TE; Bayram AS; Gebitekin C
    Eur J Cardiothorac Surg; 2019 Sep; 56(3):604-611. PubMed ID: 30809654
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Surgical treatment of non-small cell lung cancer].
    de Leyn P; Decker G
    Rev Mal Respir; 2004 Nov; 21(5 Pt 1):971-82. PubMed ID: 15622344
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Staging and the surgical management of lung cancer.
    Park BJ; Louie O; Altorki N
    Radiol Clin North Am; 2000 May; 38(3):545-61, ix. PubMed ID: 10855261
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence-based medicine in the treatment of non-small-cell lung cancer.
    Reif MS; Socinski MA; Rivera MP
    Clin Chest Med; 2000 Mar; 21(1):107-20, ix. PubMed ID: 10763093
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Staging and surgery for non-small cell lung cancer (NSCLC).
    Alpard SK; Zwischenberger JB
    Surg Oncol; 1998; 7(1-2):25-43. PubMed ID: 10421504
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New strategies in the treatment of resectable non-small cell lung cancer.
    Felip E; Rosell R
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):224-8. PubMed ID: 12113027
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Issues Relevant to Surgical Intervention in 'Tiny' Non-small Cell Lung Cancer Detected by 'Lung Screening'--Orientation, Lung Resection and Lymph Node Resection].
    Liu D; Zhang Z
    Zhongguo Fei Ai Za Zhi; 2016 Jun; 19(6):347-50. PubMed ID: 27335294
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Anatomical Lung Resection Following Neoadjuvant Chemoimmunotherapy: Technical Aspects and Case Reports].
    Eichhorn M; Eichhorn F; Griffo R; Klotz L; Winter H
    Zentralbl Chir; 2024 Aug; 149(S 01):S26-S34. PubMed ID: 39137759
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Progress in Neoadjuvant Immunotherapies for Resectable Non-small Cell Lung Cancer].
    Wang S; Mao Y
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):371-380. PubMed ID: 32283581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.